BD Selects “embecta” as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
- Monday, December 6, 2021, 7:04
- Finance
- Add a comment
FRANKLIN LAKES, N.J., Dec. 6, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that “embecta” [pronounced em-BECK-tah] will be the name of the independent, publicly-traded company that will hold BD’s Diabetes…
About the Author
adminasapcorp has written 41538 stories on this site.